SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

1. PRODUCT AND COMPANY IDENTIFICATION
Product name:Finasteride (1%) Formulation

Manufacturer or supplier's details
Company: Organon & Co.
Address:

30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302

Telephone:+1-551-430-6000

Emergency telephone number :+1-215-631-6999

E-mail address

EHSSTEWARD@organon.com:

Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable

2. HAZARDS IDENTIFICATION
Emergency Overview
Appearance
Colour
Odour

:
:
:

powdertanodourlessMay damage the unborn child. May cause damage to organs through prolonged or repeated exposure. Harmful to aquatic life with long lasting effects.
GHS Classification
Reproductive toxicity:

Category 1BSpecific target organ toxicity repeated exposure:

Category 2

Long-term (chronic) aquatic
hazard:Category 3

GHS label elements
Hazard pictograms:

Signal word:

Danger
1 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Hazard statements:

Precautionary statements:

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

H360D May damage the unborn child.
H373 May cause damage to organs through prolonged or repeated exposure.
H412 Harmful to aquatic life with long lasting effects.
Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P260 Do not breathe dust.
P273 Avoid release to the environment.
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response:
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents/ container to an approved waste
disposal plant.

Physical and chemical hazards
Not classified based on available information.
Health hazards
May damage the unborn child. May cause damage to organs through prolonged or repeated exposure.
Environmental hazards
Harmful to aquatic life with long lasting effects.
Other hazards which do not result in classification
Dust contact with the eyes can lead to mechanical irritation.
Contact with dust can cause mechanical irritation or drying of the skin.
May form explosive dust-air mixture during processing, handling or other means.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical name
Cellulose
StarchFinasteride
Titanium dioxide

CAS-No.
9004-34-6
9005-25-8
98319-26-7
13463-67-7
2 / 18

Concentration (% w/w)>= 1 -< 10>= 1 -< 10>= 1 -< 2.5>= 0.1 -< 1

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

4. FIRST AID MEASURES
General advice:

If inhaled:

In case of skin contact:

In case of eye contact:

If swallowed:

Most important symptoms
and effects, both acute anddelayed:Protection of first-aiders:

Notes to physician:

In the case of accident or if you feel unwell, seek medical advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with soap and plentyof water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
If in eyes, rinse well with water.
Get medical attention if irritation develops and persists.
If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
May damage the unborn child.
May cause damage to organs through prolonged or repeatedexposure.
Contact with dust can cause mechanical irritation or drying of
the skin.
Dust contact with the eyes can lead to mechanical irritation.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

5. FIREFIGHTING MEASURES
Suitable extinguishing media:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

Unsuitable extinguishingmedia
Specific hazards during firefighting::

Avoid generating dust; fine dust dispersed in air in sufficientconcentrations, and in the presence of an ignition source is apotential dust explosion hazard.
Exposure to combustion products may be a hazard to health.

Hazardous combustion products:

Carbon oxides
Metal oxides

Specific extinguishing methods:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to do
3 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

Special protective equipment
for firefighters

SDS Number:
49637-00024:

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

so.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.

6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emergency procedures

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal protective equipment recommendations (see section 8).

Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials forcontainment and cleaning up:

Sweep up or vacuum up spillage and collect in suitable container for disposal.
Avoid dispersal of dust in the air (i.e., clearing dust surfaces
with compressed air).
Dust deposits should not be allowed to accumulate on surfaces, as these may form an explosive mixture if they are released into the atmosphere in sufficient concentration.
Local or national regulations may apply to releases and disposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need to determine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.

Handling
Technical measures:

Local/Total ventilation:

Advice on safe handling:

Static electricity may accumulate and ignite suspended dust
causing an explosion.
Provide adequate precautions, such as electrical grounding
and bonding, or inert atmospheres.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.
Do not get on skin or clothing.
Do not breathe dust.
Do not swallow.
Avoid contact with eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure assessment
Keep container tightly closed.

7. HANDLING AND STORAGE

4 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Avoidance of contact:

Storage
Conditions for safe storage:

Materials to avoid:

Packaging material:

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Minimize dust generation and accumulation.
Keep container closed when not in use.
Keep away from heat and sources of ignition.
Take precautionary measures against static discharges.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
Oxidizing agents
Keep in properly labelled containers.
Store locked up.
Keep tightly closed.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents
Unsuitable material: None known.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Components with workplace control parameters
Components

CAS-No.

Cellulose

9004-34-6

StarchFinasteride

9005-25-8
98319-26-7

Value type
(Form ofexposure)
PC-TWA
TWA
TWA
TWA

Control parameters / Permissible
concentration
10 mg/m3
10 mg/m3
10 mg/m3
0.5 µg/m3 (OEB
5)
5 µg/100 cm²
8 mg/m3

Basis

CN OEL
ACGIH
ACGIH
Internal

Wipe limit
Internal
13463-67-7
PC-TWACN OEL(Total dust)
Further information: G2B - Possibly carcinogenic to humans
TWA (Res2.5 mg/m3
ACGIH
pirable par(Titanium dioxide)
ticulate matter)

Titanium dioxide

This substance(s) is not bioavailable and therefore does not contribute to a dust inhalation
hazard.
Titanium dioxide
Engineering measures:

Use closed processing systems or containment technologies
to control at source (e.g., glove boxes/isolators) and to prevent leakage of compounds into the workplace.
All engineering controls should be implemented by facility
design and operated in accordance with GMP principles toprotect products, workers, and the environment.
No open handling permitted.
5 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Totally enclosed processes and materials transport systems
are required.
Operations require the use of appropriate containment technology designed to prevent leakage of compounds into theworkplace.
Personal protective equipment
Respiratory protection: If adequate local exhaust ventilation is not available or exposure assessment demonstrates exposures outside the recommended guidelines, use respiratory protection.
Filter type
: Particulates type
Eye/face protection: Wear safety glasses with side shields or goggles.
If the work environment or activity involves dusty conditions,mists or aerosols, wear the appropriate goggles.
Wear a faceshield or other full face protection if there is apotential for direct contact to the face with dusts, mists, oraerosols.
Skin and body protection: Work uniform or laboratory coat.
Additional body garments should be used based upon thetask being performed (e.g., sleevelets, apron, gauntlets, disposable suits) to avoid exposed skin surfaces.
Use appropriate degowning techniques to remove potentiallycontaminated clothing.
Hand protection
Material
Remarks
Hygiene measures:

Chemical-resistant gloves::

Consider double gloving.
If exposure to chemical is likely during typical use, provide
eye flushing systems and safety showers close to the working place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.
The effective operation of a facility should include review ofengineering controls, proper personal protective equipment,
appropriate degowning and decontamination procedures,industrial hygiene monitoring, medical surveillance and theuse of administrative controls.

9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance:

powderColour

:

tan

Odour

:

odourlessOdour Threshold:

No data available

pH:

No data available

6 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Melting point/freezing point:

No data available

Initial boiling point and boiling
range

:

No data available

Flash point:

Not applicable

Evaporation rate:

Not applicable

Flammability (solid, gas):

May form explosive dust-air mixture during processing, handling or other means.

Flammability (liquids):

No data available

Upper explosion limit / Upper
flammability limit:

No data available

Lower explosion limit / Lower
flammability limit:

No data available

Vapour pressure:

Not applicable

Relative vapour density:

Not applicable

Relative density:

No data available

Density:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water:log Pow: 3.5
pH: 7
Active ingredientAuto-ignition temperature:

No data available

Decomposition temperature:

No data available

Viscosity
Viscosity, kinematic:

Not applicable

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Particle characteristics
Particle size:

No data available

7 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

10. STABILITY AND REACTIVITY
Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
May form explosive dust-air mixture during processing, handling or other means.
Can react with strong oxidizing agents.

Conditions to avoid:

Incompatible materials
Hazardous decomposition
products::

Heat, flames and sparks.
Avoid dust formation.
Oxidizing agents
No hazardous decomposition products are known.

11. TOXICOLOGICAL INFORMATION
Exposure routes:

Inhalation
Skin contact
Ingestion
Eye contact

Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 5,000 mg/kg
Method: Calculation method

Cellulose:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 5.8 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Starch:Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Finasteride:
Acute oral toxicity:

LD50 (Rat): 373 - 828 mg/kg

Components:

LD50 (Mouse): 486 mg/kg

8 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Titanium dioxide:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 6.82 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist
Assessment: The substance or mixture has no acute inhalation toxicity

Skin corrosion/irritation
Not classified based on available information.
Components:
Finasteride:
SpeciesResult::RabbitNo skin irritation

Titanium dioxide:
SpeciesResult::RabbitNo skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Starch:SpeciesResult::RabbitNo eye irritation

Finasteride:
Species
Remarks::

Rabbitslight irritation

Titanium dioxide:
SpeciesResult::RabbitNo eye irritation

Respiratory or skin sensitisation
Skin sensitisation
Not classified based on available information.
Respiratory sensitisation
Not classified based on available information.

9 / 18SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Components:
Starch:Test Type
Exposure routes
SpeciesResult::::Maximisation Test
Skin contact
Guinea pig
negative

Titanium dioxide:
Test Type
Exposure routes
SpeciesResult::::Local lymph node assay (LLNA)
Skin contact
Mouse
negative

Germ cell mutagenicity
Not classified based on available information.
Components:
Cellulose:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Result: negative

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Ingestion
Result: negative

Starch:Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Finasteride:
Genotoxicity in vitro:

Test Type: Chromosome aberration test in vitro
Result: positive
Test Type: In vitro mammalian cell gene mutation test
Result: negative
Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: Alkaline elution assay
Result: negative

10 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Genotoxicity in vivo:

Test Type: Mutagenicity (in vivo mammalian bone-marrowcytogenetic test, chromosomal analysis)
Application Route: Oral
Result: negative

Titanium dioxide:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Genotoxicity in vivo:

Test Type: In vivo micronucleus test
Species: Mouse
Result: negative

Carcinogenicity
Not classified based on available information.
Components:
Cellulose:
Species
Application RouteExposure time
Result

:
:
:
:

Rat
Ingestion
72 weeks
negative

ResultTarget Organs
Remarks

:
:
:
:
:
:
:

Rat
Ingestion
2 Years
160 mg/kg body weight
negative
TestesBenign tumor(s)Species
Application RouteExposure time
ResultTarget Organs
Remarks

:
:
:
:
:
:

Mouse
Ingestion
19 month(s)negative
TestesBenign tumor(s)Titanium dioxide:
Species
Application RouteExposure time
MethodResultRemarks

:
:
:
:
:
:

Rat
inhalation (dust/mist/fume)
2 Years
OECD Test Guideline 453
positive
The mechanism or mode of action may not be relevant in humans.
This substance(s) is not bioavailable and therefore does not

Finasteride:
Species
Application RouteExposure time

11 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

contribute to a dust inhalation hazard.
Carcinogenicity - Assessment:

Limited evidence of carcinogenicity in inhalation studies withanimals.

:

Test Type: One-generation reproduction toxicity study
Species: Rat
Application Route: Ingestion
Result: negative:

Test Type: Fertility/early embryonic development
Species: Rat
Application Route: Ingestion
Result: negative:

Test Type: Fertility/early embryonic development
Species: Rabbit
Application Route: Oral
Fertility: NOAEL: 80 mg/kg body weight
Result: No effects on fertility

Reproductive toxicity
May damage the unborn child.
Components:
Cellulose:
Effects on fertility

Effects on foetal development

Finasteride:
Effects on fertility

Test Type: Fertility/early embryonic development
Species: Rat
Application Route: Ingestion
Fertility: LOAEL: 80 mg/kg body weight
Result: positive
Remarks: There is no evidence that these findings are relevant to humans.
Effects on foetal development:

Test Type: Embryo-foetal development
Species: Rat
Application Route: Ingestion
Developmental Toxicity: LOAEL: 0.003 mg/kg body weight
Result: Teratogenic effects, Embryotoxic effects.
Test Type: Embryo-foetal development
Species: Monkey
Application Route: Ingestion
Developmental Toxicity: LOAEL: 2 mg/kg body weight
Result: Teratogenic effects

Reproductive toxicity - Assessment:

Clear evidence of adverse effects on development, based onanimal experiments.
12 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

STOT - single exposure
Not classified based on available information.
STOT - repeated exposure
May cause damage to organs through prolonged or repeated exposure.
Components:
Finasteride:
Exposure routes
Target Organs
Assessment:::

Ingestion
Testis
Causes damage to organs through prolonged or repeatedexposure.

Cellulose:
Species
NOAEL
Application RouteExposure time

:
:
:
:

Rat
>= 9,000 mg/kg
Ingestion
90 Days

Starch:Species
NOAEL
Application RouteExposure time
Method

:
:
:
:
:

Rat
>= 2,000 mg/kg
Skin contact
28 Days
OECD Test Guideline 410

Finasteride:
Species
NOAEL
LOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:
:

Rat
20 mg/kg
40 mg/kg
Oral
1 yr
TestisSpecies
NOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:

Dog
45 mg/kg
Oral
1 yr
TestisTitanium dioxide:
Species
NOAEL

:
:

Rat
24,000 mg/kg

Repeated dose toxicity
Components:

13 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Application RouteExposure time::

Ingestion
28 DaysSpecies
NOAEL
Application RouteExposure time

:
:
:
:

Rat
10 mg/m3
inhalation (dust/mist/fume)
2 yr

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Finasteride:
Ingestion:

Symptoms: breast tenderness, breast enlargement, impotence, lip swelling, skin rash

Cellulose:
Toxicity to fish:

LC50 (Oryzias latipes (Japanese medaka)): > 100 mg/l
Exposure time: 48 h
Remarks: Based on data from similar materials

Finasteride:
Toxicity to fish:

LC50 (Oncorhynchus mykiss (rainbow trout)): 20.4 mg/l
Exposure time: 96 h
Method: FDA 4.11

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): 17.8 mg/l
Exposure time: 48 h
Method: FDA 4.08

Toxicity to algae/aquaticplants:NOEC (Pseudokirchneriella subcapitata (green algae)): 49
mg/l
Exposure time: 14 h
Method: FDA 4.01

Toxicity to fish (Chronic toxicity):

NOEC (Oryzias latipes (Orange-red killifish)): 0.05 mg/l
Exposure time: 105 d

12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:

Toxicity to daphnia and other :aquatic invertebrates (Chronic toxicity)

NOEC (Daphnia magna (Water flea)): 0.12 mg/l
Exposure time: 21 d
Method: OECD Test Guideline 211
14 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

M-Factor (Chronic aquatic
toxicity)

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

:

1

:

LC50 (Oncorhynchus mykiss (rainbow trout)): > 100 mg/l
Exposure time: 96 h
Method: OECD Test Guideline 203

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 100 mg/l
Exposure time: 48 h

Toxicity to algae/aquaticplants:

EC50 (Skeletonema costatum (marine diatom)): > 10,000 mg/l
Exposure time: 72 h

Toxicity to microorganisms:

EC50: > 1,000 mg/l
Exposure time: 3 hMethod: OECD Test Guideline 209

Titanium dioxide:
Toxicity to fish

Persistence and degradability
Components:
Cellulose:
Biodegradability:

Result: Readily biodegradable.

Finasteride:
Biodegradability:

Result: Not readily biodegradable.
Biodegradation: 0 %Exposure time: 7 dMethod: FDA 3.11

Stability in water:

Hydrolysis: 0 %(5 d)Method: FDA 3.09:

log Pow: 3.57

Bioaccumulative potential
Components:
Finasteride:
Partition coefficient: noctanol/water
Mobility in soil
No data available
Other adverse effects
No data available

15 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Do not dispose of waste into sewer.
Dispose of in accordance with local regulations.
Empty containers should be taken to an approved waste handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

:
:
:
:
:
:
:

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicable
no

:
:
:
:
:
:
:

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicable:Not applicable

:
:
:
:
:
:
:
:

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicable
no14. TRANSPORT INFORMATIONInternational Regulations
UNRTDGUN number
Proper shipping nameClass
Subsidiary risk
Packing group
LabelsEnvironmentally hazardous
IATA-DGR
UN/ID No.
Proper shipping nameClass
Subsidiary risk
Packing group
LabelsPacking instruction (cargo
aircraft)Packing instruction (passenger aircraft)
IMDG-CodeUN number
Proper shipping nameClass
Subsidiary risk
Packing group
LabelsEmS Code
Marine pollutant

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC CodeNot applicable for product as supplied.
National Regulations
GB 6944/12268
UN number
Proper shipping name::Not applicableNot applicable
16 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

Class
Subsidiary risk
Packing group
LabelsMarine pollutant

SDS Number:
49637-00024

:
:
:
:
:

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

Not applicableNot applicableNot applicableNot applicablenoSpecial precautions for user
Not applicable
15. REGULATORY INFORMATION
National regulatory information
Law on the Prevention and Control of Occupational Diseases
Regulation on the Administration of Precursor Chemicals
Catalogue and Classification of Precursor Chemicals:

Not listed

Yangtze River Protection Law
This product does not contain any dangerous chemicals prohibited for inland river transport.
The components of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

Revision Date:

2024/04/06

Further information
Sources of key data used tocompile the Safety Data
Sheet

:

Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Date format:

yyyy/mm/dd

16. OTHER INFORMATION

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
CN OEL: Occupational exposure limits for hazardous agents in theworkplace - Chemical hazardous agents.
ACGIH / TWA
CN OEL / PC-TWA::

8-hour, time-weighted average
Permissible concentration - time weighted average

AIIC - Australian Inventory of Industrial Chemicals; ANTT - National Agency for Transport byLand of Brazil; ASTM - American Society for the Testing of Materials; bw - Body weight; CMR Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute forStandardisation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with17 / 18

SAFETY DATA SHEET
according to GB/T 16483 and GB/T 17519

Finasteride (1%) Formulation
Version
8.2

Revision Date:
2024/04/06

SDS Number:
49637-00024

Date of last issue: 2023/09/30
Date of first issue: 2015/01/26

x% response; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; IARC - International Agency for Research on Cancer; IATA
- International Air Transport Association; IBC - International Code for the Construction andEquipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime Dangerous Goods; IMO - International
Maritime Organization; ISHL - Industrial Safety and Health Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to 50% of a test population (Median
Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships;
n.o.s. - Not Otherwise Specified; Nch - Chilean Norm; NO(A)EC - No Observed (Adverse) EffectConcentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable EffectLoading Rate; NOM - Official Mexican Norm; NTP - National Toxicology Program; NZIoC - New
Zealand Inventory of Chemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; REACH - Regulation (EC) No
1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; SADT - Self-Accelerating Decomposition Temperature; SDS - Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TDG - Transportation of Dangerous Goods; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN - United Nations; UNRTDG - United Nations Recommendations on the Transport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative; WHMIS - Workplace Hazardous Materials Information System
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information is designed only as a guidance forsafe handling, use, processing, storage, transportation, disposal and release and shall not be
considered a warranty or quality specification of any type. The information provided relates only
to the specific material identified at the top of this SDS and may not be valid when the SDS material is used in combination with any other materials or in any process, unless specified in the text.
Material users should review the information and recommendations in the specific context of theirintended manner of handling, use, processing and storage, including an assessment of the appropriateness of the SDS material in the user’s end product, if applicable.
CN / EN

18 / 18